Sonobe H, Hayashi K, Takahashi K, Ohtsuki Y, Matsumoto K, Onishi S, Jinno K
Department of Pathology, Kochi Medical School, Japan.
Acta Pathol Jpn. 1987 Dec;37(12):1945-52. doi: 10.1111/j.1440-1827.1987.tb03308.x.
A rare case of combined hepatocellular and cholangiocarcinoma arising in a 56-year-old female is reported. The autopsy disclosed the presence of two different kinds of tumors in the right lobe of the liver, which showed advanced cirrhosis; a massive rubbery, ill-defined and whitish-yellow cholangiocarcinoma and a nodular soft, encapsulated and dark green hepatocellular carcinoma. They were adjacent to each other, but showed no intermingling. Only the massive cholangiocarcinoma had invaded the portal vein and showed several intrahepatic metastatic foci and hepatic, pancreaticoduodenal and perigastric lymph node metastases. Immunohistochemically, carbohydrate antigen 19-9 was strongly positive only for the cholangiocarcinoma component, explaining the high titer of this antigen in the serum on admission. On the basis of these findings, the possible morphogenesis of the tumor observed in the cirrhotic liver is discussed.
报告了一例56岁女性发生的罕见的肝细胞癌和胆管癌合并病例。尸检发现肝脏右叶存在两种不同类型的肿瘤,伴有晚期肝硬化;一个巨大的橡皮样、边界不清的灰白色胆管癌和一个结节状、质地柔软、有包膜的深绿色肝细胞癌。它们彼此相邻,但没有相互混杂。只有巨大的胆管癌侵犯了门静脉,并出现了几个肝内转移灶以及肝、胰十二指肠和胃周淋巴结转移。免疫组化显示,糖类抗原19-9仅在胆管癌成分中呈强阳性,这解释了入院时血清中该抗原的高滴度。基于这些发现,讨论了在肝硬化肝脏中观察到的肿瘤可能的形态发生机制。